Anticancer Therapies – News and Features
Study Shows Genetically Modified Cells Attack Tumors
St. Jude researchers have treated tumors with genetically modified cells that sought out and activated a chemotherapy drug placed directly at the cancer cells.
Researchers Find That a Silent Gene Mutation can Change the Function of an Anticancer Drug Pump
The mutations involving single chemical bases in a gene, not affecting the protein sequence of the gene product, can alter the protein's drug binding ability.
Launch of New Center for Proteomics and Drug Actions
Vanderbilt University Medical Center and the National Foundation for Cancer Research have established a cancer research center from $1 million funded by NFCR.
Key Immune Cells Predict Recurrence in Lung Cancer Patients
Researchers found that the more T-regulatory cells and the fewer T-cell lymphocytes present in the tumors of treated patients, the greater the likelihood the cancer would recur.
A Prospective Clinical Trial for Managing Chemotherapeutic Options in Breast Cancer
Ipsogen and a group of cancer centres lead by Institut Paoli-Calmettes have initiated the clinical trial for managing chemotherapeutic options in breast cancer.
Molecular 'Marker' on Stem Cells Aids Research
The molecule, called SSEA-4, found on the surface of certain stem cells in bone marrow can give rise to fat, cartilage and bone.
Geneservice Announces Agreement to Distribute Biological Resources Developed by Roswell Park Cancer Institute
The license agreement reinforces Geneservice's position as the provider of biological and genomic resources to life science researchers worldwide.
MorphoSys and the Burnham Institute Sign Broad Research Partnership
The Burnham will receive access to novel HuCAL GOLD-based research antibodies.
Biothera Initiates Phase I/II Clinical Trial for Stem Cell Mobilization
The trial will evaluate the effects of Imprime PGG™ in combination with G-CSF for mobilization of bone marrow stem cells into the peripheral blood.
Targeting Leukemic Stem Cells by BCL-2 Inhibition
The combination of two experimental drugs provides the synergistic action against acute myeloid leukemia cells.